GeneTrails® – Pioneering Diagnostics for Cancer
The Knight Diagnostic Laboratories specialize in creating panels of tests that are useful in cancer genetics and oncology. We are among the early leaders in adapting next-generation sequencing technologies to meet the standards of clinical testing. By combining amplicon-based DNA library preparation with semiconductor sequencing (Ion Torrent PGM platform), we deliver information on DNA sequence variants and mutations in a rapid, sensitive, and cost-effective manner. In some cases the next gen
sequencing is complemented with FISH assays that can identify gene translocations and amplifications that are clinically actionable. Immunohistochemistry is also employed in some cases. Thus, our approach maximizes the use of different technologies to ensure that the reported results are both diagnostic and useful for clinical management.
GeneTrails® Cancer Panels
The Knight Diagnostic Laboratories have developed a new panel of tests for the molecular subclassification of Non-Small Cell Lung Cancer (NSCLC) and Gastrointestinal Stromal Tumor (GIST), as well as the new AML/MDS Genotyping Panel.
Available Cancer Panels
GeneTrails® Panels Coming Soon
Unsure what panel of tests may be best for your patient? Our medical specialists are available to consult and can help you decide which GeneTrails® tests will fit your patient's needs. Contact Knight Diagnostic Laboratories Client Services today.